Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial.

Abstract:

:The German Society of Pediatric Oncology in 1981 initiated the Cooperative Ewing's Sarcoma Study (CESS 81) using a four-drug combination of chemotherapy prior to definitive local control with surgery and/or radiation. From January 1, 1981 until February 28, 1985, 93 patients were registered at the trial office from 54 participating institutions in West Germany, Austria, Switzerland, and the Netherlands. On February 1, 1987, 54 of 93 patients were disease-free. Using the Kaplan-Meier life table analysis, the estimated disease-free survival (DFS) rate was 60% at 36 months and 55% at 69 months. The median period of observation was 29 months, ranging from 22 months to 69 months. Twenty-one of 93 patients (23%) had local failure, 18 of 93 patients (19%) developed systemic metastases. The local failure rate was particularly high in patients treated with radiation and was reduced when radiation planning was centralized within the study based upon the extent of disease at diagnosis. Cox regression analysis of prognostic factors showed that tumor volume was a significant factor influencing prognosis. The estimated 3-year DFS rate was 80% for patients with small tumors (volume less than 100 ml) compared to 31% for patients with large tumors (volume greater than or equal to 100 ml). In patients who had surgery for local control, the histologic response to chemotherapy was analyzed on the surgical specimen and had a strong influence on survival: 79% DFS at 3 years for patients with less than 10% viable tumor (good responders) compared to 31% DFS for patients with more than 10% viable tumor (poor responders). Tumor load and responsiveness to chemotherapy are the two major factors influencing prognosis in patients with primary Ewing's sarcoma of bone.

journal_name

Cancer

journal_title

Cancer

authors

Jürgens H,Exner U,Gadner H,Harms D,Michaelis J,Sauer R,Treuner J,Voûte T,Winkelmann W,Winkler K

doi

10.1002/1097-0142(19880101)61:1<23::aid-cncr282061

subject

Has Abstract,Author List Incomplete

pub_date

1988-01-01 00:00:00

pages

23-32

issue

1

eissn

0008-543X

issn

1097-0142

journal_volume

61

pub_type

杂志文章

相关文献

CANCER文献大全
  • Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.

    abstract:BACKGROUND:The expression of vascular endothelial growth factor (VEGF)-A isoforms (121, 165, 189, 206), VEGF-B, VEGF-C and VEGF-D in both experimental and clinical models of head and neck squamous cell carcinoma (HNSCC) was determined and correlated with conventional clinicopathologic parameters, with particular refere...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>

    authors: O-charoenrat P,Rhys-Evans P,Eccles SA

    更新日期:2001-08-01 00:00:00

  • Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.

    abstract:BACKGROUND:The presence of urinary excretion products of human chorionic gonadotropin (hCG) has been proposed as a tumor marker. To ascertain the clinical value in gynecologic cancers, the authors studied 612 nonpregnant women. METHODS:Three different assays in four clinical groups were compared: no disease, benign di...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930615)71:12<4124::aid-cncr282

    authors: Neven P,Iles RK,Lee CL,Hudson CN,Shepherd JH,Chard T

    更新日期:1993-06-15 00:00:00

  • Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.

    abstract:BACKGROUND:Children with acute lymphoblastic leukemia with multiple poor prognostic factors and who have a lymphomatous mass at diagnosis, whether of T- or non-T-immunophenotype, are at increased risk of short term remission and extramedullary recurrence, and are in need of better therapies. METHODS:Six hundred and ni...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0142(19980201)82:3<600::aid-cnc

    authors: Steinherz PG,Gaynon PS,Breneman JC,Cherlow JM,Grossman NJ,Kersey JH,Johnstone HS,Sather HN,Trigg ME,Uckun FM,Bleyer WA

    更新日期:1998-02-01 00:00:00

  • Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience.

    abstract::Two hundred seventy-nine consecutive patients with Stage II osteogenic sarcoma of the appendicular skeleton treated between 1976 and 1986 were studied to identify predictors of long-term survival. Survival was 77% and 73% at 5 and 10 years, respectively, with continuously disease-free survival being 70% and 69%. On un...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920201)69:3<698::aid-cncr28206

    authors: Glasser DB,Lane JM,Huvos AG,Marcove RC,Rosen G

    更新日期:1992-02-01 00:00:00

  • Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study.

    abstract:BACKGROUND:Studies regarding different ethnic populations of children with Wilms' tumor (WT) in the U. S. have shown differences between age and gender incidence and the type of its precursor lesions (nephrogenic rests). To the authors' knowledge there are few reports in the literature regarding nephrogenic rests in a ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Mishra K,Mathur M,Logani KB,Kakkar N,Krishna A

    更新日期:1998-11-15 00:00:00

  • Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors.

    abstract:BACKGROUND:Ewing sarcoma family of tumors (ESFTs) are the second most common bone tumor, that most often affects persons ages 3-40 years. The ESFTs rely on signaling through the insulin-like growth factor-1 receptor (IGF-1R) for growth and transformation. The current studies were performed to determine the levels of IG...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011201)92:11<2941::aid-cncr100

    authors: Toretsky JA,Steinberg SM,Thakar M,Counts D,Pironis B,Parente C,Eskenazi A,Helman L,Wexler LH

    更新日期:2001-12-01 00:00:00

  • Prospects for monoclonal antibody therapy of leukemia and lymphoma.

    abstract::The development of monoclonal antibodies has led to renewed interest in the use of antibodies to treat malignant disease. Unfortunately, treatment with unmodified antibodies has been disappointing. Therapy with unmodified antibodies has been limited by the failure of host effector mechanisms to eliminate antibody-coat...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19860715)58:2+<584::aid-cncr2820

    authors: Badger CC,Bernstein ID

    更新日期:1986-07-15 00:00:00

  • Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.

    abstract:BACKGROUND:Currently, there is very low-quality evidence available regarding benefit of surgical resection of the primary tumor (SRPT), in patients with stage IV colorectal cancer (CRC). In the absence of randomization, the reported benefit may reflect selection of younger and healthier patients with good performance s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28464

    authors: Ahmed S,Leis A,Fields A,Chandra-Kanthan S,Haider K,Alvi R,Reeder B,Pahwa P

    更新日期:2014-03-01 00:00:00

  • The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy.

    abstract::Elevated serum levels of carcinoembryonic antigen (CEA) were found in 70% of 141 patients with advanced gastrointestinal (GI) cancers. Serial CEA measurements were performed on 70 patients before and during chemotherapy. The majority were treated with 5-FU and Methyl-CCNU (33 patients), 5-FU (19 patients), or 5-FU and...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197910)44:4<1222::aid-cncr282044

    authors: Al-Sarraf M,Baker L,Talley RW,Kithier K,Vaitkevicius VK

    更新日期:1979-10-01 00:00:00

  • Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia.

    abstract::The glucocorticoid receptor (GR) quantitation by a whole-cell assay and/or cytosol technique and the in vitro sensitivity to steroids have been assessed in peripheral blood cells from normal donors and patients with chronic lymphatic leukemia (CLL), acute lymphoblastic leukemia (ALL), lymphosarcoma cell leukemia (LSCL...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820215)49:4<623::aid-cncr28204

    authors: Nanni P,Nicoletti G,Prodi G,Galli MC,De Giovanni C,Grilli S,Lollini PL,Gobbi M,Cavo M,Tura S

    更新日期:1982-02-15 00:00:00

  • Treatment of the neck in patients with squamous cell carcinoma of the head and neck.

    abstract::A retrospective study of 702 patients with clinically positive nodes associated with squamous cell carcinoma of the oral cavity, supraglottic larynx, and hypopharynx observed from 1954 to 1968 was done. The policies of treatment for the neck were not standardized during those years. Three hundred eleven patients who s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197702)39:2+<868::aid-cncr282039

    authors: Jesse RH,Fletcher GH

    更新日期:1977-02-01 00:00:00

  • What do transplant physicians think about palliative care? A national survey study.

    abstract:BACKGROUND:Despite its established benefits, palliative care (PC) is rarely utilized for hematopoietic stem cell transplant (HSCT) patients. We sought to examine transplant physicians' perceptions of PC. METHODS:We conducted a cross-sectional survey of transplant physicians recruited from the American-Society-for-Bloo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31709

    authors: El-Jawahri A,LeBlanc TW,Burns LJ,Denzen E,Meyer C,Mau LW,Roeland EJ,Wood WA,Petersdorf E

    更新日期:2018-12-01 00:00:00

  • The chemotherapy of Hodgkin's disease: past experiences and future directions.

    abstract::From the standpoint of chemotherapy, the first progress in the treatment of Hodgkin's disease was the identification of the activity of nitrogen mustard in the 1940's. The initial antitumor effect of the drug created a great excitement. However, when all patients later relapsed, there was subsequent dejection and skep...

    journal_title:Cancer

    pub_type: 临床试验,历史文章,杂志文章,评审

    doi:10.1002/1097-0142(197808)42:2+<979::aid-cncr282042

    authors: DeVita VT Jr,Lewis BJ,Rozencweig M,Muggia FM

    更新日期:1978-08-01 00:00:00

  • A nomogram predicting long-term biochemical recurrence after radical prostatectomy.

    abstract:BACKGROUND:Men who undergo radical prostatectomy (RP) are at long-term risk of biochemical recurrence (BCR). In this report, the authors have described a model capable of predicting BCR up to at least 15 years after RP that can adjust predictions according to the disease-free interval. METHODS:Cox regression was used ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23293

    authors: Suardi N,Porter CR,Reuther AM,Walz J,Kodama K,Gibbons RP,Correa R,Montorsi F,Graefen M,Huland H,Klein EA,Karakiewicz PI

    更新日期:2008-03-15 00:00:00

  • Gauging the impact of breast carcinoma screening in terms of tumor size and death rate.

    abstract:BACKGROUND:While the question of whether the trials of breast cancer screening have resulted in a reduction in breast cancer death has been the subject of much scrutiny, there has been less attention to the reduction in tumor size achieved by screening. METHODS:Size data for invasive breast tumors were assembled from ...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.11766

    authors: Michaelson JS,Satija S,Kopans D,Moore R,Silverstein M,Comegno A,Hughes K,Taghian A,Powell S,Smith B

    更新日期:2003-11-15 00:00:00

  • Anaphylactoid reactions to methotrexate.

    abstract:BACKGROUND:Methotrexate is a chemotherapeutic agent frequently utilized for the treatment of malignant, rheumatic, and pulmonary diseases. Although this agent has been extensively used for more than 45 years, there are few reports of immediate systemic hypersensitivity reactions. The reported immediate reactions includ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(SICI)1097-0142(19960515)77:10<2123::AID-C

    authors: Alkins SA,Byrd JC,Morgan SK,Ward FT,Weiss RB

    更新日期:1996-05-15 00:00:00

  • Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen.

    abstract:BACKGROUND:Insulin-like growth factor I (IGF-I) is a potent mitogen for breast cancer cells. The majority of IGF-I in plasma is bound to IGF binding proteins (IGFBPs), which modulate the biologic effects of IGF-I. METHODS:Plasma concentrations of IGF-I, IGFBP-I, and IGFBP-3 were compared between 40 postmenopausal brea...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940715)74:2<618::aid-cncr28207

    authors: Lahti EI,Knip M,Laatikainen TJ

    更新日期:1994-07-15 00:00:00

  • Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field.

    abstract:BACKGROUND:Single-walled carbon nanotubes (SWNTs) have remarkable physicochemical properties that may have several medical applications. The authors have discovered a novel property of SWNTs-heat release in a radiofrequency (RF) field-that they hypothesized may be used to produce thermal cytotoxicity in malignant cells...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23155

    authors: Gannon CJ,Cherukuri P,Yakobson BI,Cognet L,Kanzius JS,Kittrell C,Weisman RB,Pasquali M,Schmidt HK,Smalley RE,Curley SA

    更新日期:2007-12-15 00:00:00

  • Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy.

    abstract:BACKGROUND:The influence of HER-2/neu on prognosis of breast cancer is controversial. The authors investigated by immunohistochemistry in node-positive disease the influence of the pattern of immunostaining (membranous or cytoplasmic) on outcome and the prognostic significance of this marker in patients receiving or no...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/1097-0142(19940501)73:9<2359::aid-cncr2820

    authors: Têtu B,Brisson J

    更新日期:1994-05-01 00:00:00

  • Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:A phase 1 trial was used to evaluate a combination of cisplatin, gemcitabine, and escalating doses of veliparib in patients with untreated advanced pancreatic ductal adenocarcinoma (PDAC) in 2 cohorts: a germline BRCA1/2-mutated (BRCA+) cohort and a wild-type BRCA (BRCA-) cohort. The aims were to determine t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31218

    authors: O'Reilly EM,Lee JW,Lowery MA,Capanu M,Stadler ZK,Moore MJ,Dhani N,Kindler HL,Estrella H,Maynard H,Golan T,Segal A,Salo-Mullen EE,Yu KH,Epstein AS,Segal M,Brenner R,Do RK,Chen AP,Tang LH,Kelsen DP

    更新日期:2018-04-01 00:00:00

  • Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

    abstract:BACKGROUND:Improvements in quality of life after treatment with recombinant human erythropoietin (rHuEPO) often have been reported in patients with end-stage renal disease. In patients with chronic anemia of cancer, comparatively few systemic investigations have been performed. METHODS:Various aspects of quality of li...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940515)73:10<2535::aid-cncr282

    authors: Leitgeb C,Pecherstorfer M,Fritz E,Ludwig H

    更新日期:1994-05-15 00:00:00

  • Diffuse pagetoid squamous cell carcinoma in situ of the esophagus: a case report.

    abstract:BACKGROUND:In Western countries, esophageal squamous cell carcinoma is usually advanced at presentation and is rarely diagnosed in situ. The authors studied an in situ squamous cell carcinoma that occupied the entire mucosa of a 9 cm length of esophagus, causing dysphagia for solid food in a woman aged 68 years. METHO...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Chu P,Stagias J,West AB,Traube M

    更新日期:1997-05-15 00:00:00

  • Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.

    abstract:BACKGROUND:Synovial sarcomas are high-grade soft tissue neoplasms often characterized by a biphasic spindle and epithelioid cell morphology. The majority of synovial sarcomas harbor a specific chromosomal translocation in which the proximal portion of the SYT gene at chromosome 18q11 is fused to the distal portion of o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20847

    authors: Thomas DG,Giordano TJ,Sanders D,Biermann S,Sondak VK,Trent JC,Yu D,Pollock RE,Baker L

    更新日期:2005-02-15 00:00:00

  • Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.

    abstract::Between March 1973, and December 1976, 22 patients who developed disease progression during or after MOPP therapy were treated with a new combination, B-CAVe (Bleomycin 5 mg/m2 iv days 1, 28, 35; CCNU 100 mg/m2 po day 1; adriamycin 60 mg/m2 iv day 1; and vinblastine 5 mg/m2 iv day 1). Objective responses were achieved...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<1670::aid-cncr282041

    authors: Porzig KJ,Portlock CS,Robertson A,Rosenberg SA

    更新日期:1978-05-01 00:00:00

  • Treatment for lymphedema of the arm--the Casley-Smith method: a noninvasive method produces continued reduction.

    abstract:BACKGROUND:This paper gives an outline of the Casley-Smith method for the treatment of lymphedema of the arm. It includes a brief summary of the development of manual techniques and the terminology applied to them. METHODS:The four principles of this method are skin care, manual lymphatic drainage, compression in the ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(19981215)83:12b+<2843::aid

    authors: Casley-Smith JR,Boris M,Weindorf S,Lasinski B

    更新日期:1998-12-15 00:00:00

  • Gastric perforation secondary to metastatic carcinoma of the lung: a case report.

    abstract::This is a report of a gastric perforation secondary to a metastasis from a primary squamous cell carcinoma of the lung in a 70-year-old white man who was being treated with cimetidine for a presumed benign gastric ulcer. The literature concerning bronchogenic carcinoma metastasizing to the stomach and small bowel is r...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801015)46:8<1879::aid-cncr2820

    authors: Fletcher MS

    更新日期:1980-10-15 00:00:00

  • Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.

    abstract:BACKGROUND:Patients with aggressive non-Hodgkin lymphoma (NHL) require intensive and extensive therapy, which seems impracticable in elderly patients due to hematologic and extrahematologic toxicity. Consequent dose reduction and therapy attenuation can reduce treatment-related toxicity but also decreases therapeutic e...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.11032

    authors: Rigacci L,Carpaneto A,Alterini R,Carrai V,Bernardi F,Bellesi G,Longo G,Bosi A,Rossi Ferrini P

    更新日期:2003-01-01 00:00:00

  • Tumor vaccine for ovarian carcinoma targeting sperm protein 17.

    abstract:BACKGROUND:The authors previously identified sperm protein 17 (Sp17) as being expressed in patients with multiple myeloma. The restricted expression of Sp17 in normal tissue makes it an ideal target for tumor vaccine. In the current study, the authors extended their research to include ovarian carcinoma. METHODS:A pai...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10506

    authors: Chiriva-Internati M,Wang Z,Salati E,Timmins P,Lim SH

    更新日期:2002-05-01 00:00:00

  • The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.

    abstract:BACKGROUND:Several studies have shown that Ashkenazi Jews in the United States and Israel have a high prevalence of the founder mutations BRCA1 185delAG, BRCA1 5382insC, BRCA2 6174delT, and APC I1307K at frequencies of 1.0--1.1%, 0.2--0.3%, 0.6--1.4%, and 6.1--7.0%, respectively. The objective of this study was to comp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010715)92:2<440::aid-cncr1340>

    authors: Bahar AY,Taylor PJ,Andrews L,Proos A,Burnett L,Tucker K,Friedlander M,Buckley MF

    更新日期:2001-07-15 00:00:00

  • Fanconi anemia. Oxymetholone hepatic tumors, and chromosome aberrations associated with leukemic transition.

    abstract::Jaundice and hepatomegaly developed in a boy with Fanconi anemia after he had undergone treatment with oxymetholone for nine years. A liver scan showed patchy uptake consistent with the presence of space-occupying lesions. After oxymetholone treatment was stopped, the jaundice resolved, the liver size decreased, and t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800915)46:6<1401::aid-cncr2820

    authors: Obeid DA,Hill FG,Harnden D,Mann JR,Wood BS

    更新日期:1980-09-15 00:00:00